ENABLING PLATFORM
StarDeep™
Wearable signal intelligence, compact models, evidence and governance.
Explore the platform →FOR STRATEGIC PARTNERS + INVESTORS
The privacy-preserving metabolic intelligence platform for consumer wearables.
NeuTigers turns existing consumer wearables into a metabolic intelligence platform, backed by proprietary Edge-AI and clinical evidence. SweetDeep is its first commercial application in development. We build software, not hardware.
ONE NEUTIGERS STORY
One platform. One first application. One path to scale.
StarDeep is the enabling technology and evidence platform. SweetDeep is the first application built on it. Strategic partners provide the hardware, market access and deployment context.
FIRST APPLICATION
SweetDeep™
A metabolic-wellness experience for compatible consumer wearables.
See the product →COMMERCIAL ROUTE
Partner deployment
Licensing, integration and evidence programs with strategic partners.
Choose a path →Supporting detail: Why now
SWEETDEEP™ · FIRST COMMERCIAL APPLICATION IN DEVELOPMENT
A simpler daily view of metabolic wellness.
SweetDeep demonstrates how the NeuTigers platform can translate patterns in compatible smartwatch signals into personal trends and practical wellness guidance.
- Works with compatible consumer wearables, without new NeuTigers hardware
- Runs compact AI close to the sensor where the partner architecture allows
- Supports metabolic-wellness awareness and healthy-habit decisions
Supporting detail: The health challenge
FIVE PROOF POINTS
Evidence and execution that are difficult to replicate.
These are the five facts NeuTigers wants strategic partners and investors to remember. Research performance remains separate from consumer product claims.
in the NeuTigers cardiometabolic research portfolio
completed or initiated across three continents
reported in a public 285-participant SweetDeep preprint
completed on an established consumer wearable platform
supporting the path from validation to deployment
WHY NEUTIGERS IS DIFFERENT
Capabilities often offered separately, combined in one platform.
NeuTigers is positioned between the wearable sensor and the partner experience. The differentiation is the combination, not one isolated algorithm.
HARDWARE MODEL
Existing consumer wearables
No NeuTigers-manufactured device and no additional consumer hardware requirement.
COMPUTE + PRIVACY
Compact Edge-AI
Models designed to operate close to the sensor, subject to the final partner configuration.
EVIDENCE MOAT
Participant-linked knowledge
Wearable physiology connected with CGM, biomarkers, clinical reference data and outcomes.
ROUTE TO MARKET
Partner-led deployment
B2B licensing, integration and co-development through established device and health channels.
This combination distinguishes NeuTigers from hardware-first research wearables, cloud-only analytics and broad remote-care platforms. Individual competitor capabilities vary and should be assessed in qualified diligence.
Supporting detail: Current solution gaps
PRIMARY AUDIENCES
Built for strategic partners and investors.
The consumer experience demonstrates the technology. Partners and investors are the audiences that can help move it from validated capability to commercial scale.
STRATEGIC PARTNERS
Integrate or validate a defined use case.
Wearable OEMs can evaluate device integration. Pharma and life-science teams can explore digital biomarkers, evidence programs and controlled research workflows.
Explore partnership models ↗INVESTORS
Back the transition from validation to recurring revenue.
NeuTigers has working applications, a completed Samsung Galaxy Watch POC and a multinational evidence base. The next commercial milestone is recurring licensing or deployment.
Review the investor overview ↗Supporting detail: Market opportunity
TWO CLEARLY SEPARATED PATHS
Wellness today. Medical claims only through a regulated pathway.
The same research foundation may inform both paths, but the intended uses, claims, evidence requirements and regulatory status remain separate.
SweetDeep metabolic wellness
Personal trends, wellness education and healthy-habit support. No diagnosis, glucose measurement, disease screening or medical recommendation.
See the wellness experience →Diabetes-risk research
Study models evaluate non-invasive risk-identification questions. Any future medical function requires the applicable regulatory authorization before commercial use.
See the evidence boundary →Supporting detail: Wearable intelligence flow
COMMERCIAL CONVERSION